Contrast MammographyIlluminating breast cancer detection with contrast mammography.
SIGNA™ Architect – 70 cmNow the potential for MR is even more astonishing with the SIGNA™ Architect, a state-of-the-art imaging solution that combines the advancements in MR technology with GE Healthcare's intuitive engineering. Fueled by the SIGNA™Works productivity platform, the SIGNA™ Architect is a harmonious design of form and function.
Seno Iris GE Mammography Solution
Digital breast tomosynthesis (DBT) is making it easier to spot breast cancer. But this data-intensive technology can push the limits of some viewing tools, limiting your ability to efficiently and accurately diagnose patients.
With Seno IrisTM you can improve your reading workflow with a whole set of tools designed to effectively manage large amounts of data and help you make a quick and accurate diagnosis.
LOGIQ™ E10 UltrasoundEvery day, you have the opportunity to make a real difference in the lives of your patients. We want to empower you to do just that with the LOGIQ™ E10 by supporting your expertise and helping you to harness a new standard in imaging.
Pristina SerenaPristina Serena helps make the inaccessible accessible.
Accessibility to the area of interest is often challenging for patients with small, thin breasts, implants, or breasts with superficial, deep or very superior lesions. This often makes accurate biopsies difficult. Until now. We’ve redesigned the biopsy experience to maximize confidence for radiologists, efficiency for technologists, and help reduce anxiety for patients.
Invenia ABUS 2.0Use remarkable image quality, the coronal view, and advanced interpretation tools to look differently at dense breast tissue for adjunctive screening and diagnostic exams.
READY ViewQuantified MR image analysis to enable accurate, confident diagnoses.
One Stop Clinic
One place. One team. One day.
What if you could provide a same-day breast cancer diagnosis and treatment plan for your patients with a suspect breast finding?
7. Colorectal cancer: imaging surveillance following resection of primary tumour. Ken Milescorresponding authora and Guy Burkillb. Cancer Imaging. 2007; 7(Special issue A): S143–S149.